Rep. Bucshon: Lawmakers Introduces Legislation to Expand Nation's Diagnostic Testing Capabilities
March 06, 2020
March 06, 2020
WASHINGTON, March 6 -- Rep. Larry Bucshon, R-Indiana, issued the following news release:
U.S. Reps. Diana DeGette (D-CO) and Larry Bucshon, M.D. (R-IN) introduced bipartisan legislation establishing a risk based framework for overseeing in vitro clinical tests (IVCTs), such as test kits and laboratory developed tests (LDTs), at the Food and Drug Administration (FDA).
The Verifying Accurate, Leading-edge IVCT Development, or VALID, Act - would create a new product catego . . .
U.S. Reps. Diana DeGette (D-CO) and Larry Bucshon, M.D. (R-IN) introduced bipartisan legislation establishing a risk based framework for overseeing in vitro clinical tests (IVCTs), such as test kits and laboratory developed tests (LDTs), at the Food and Drug Administration (FDA).
The Verifying Accurate, Leading-edge IVCT Development, or VALID, Act - would create a new product catego . . .